We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Rebuffs Janssen's Imbruvica to Treat Waldenstrom's Macroglobulinemia
NICE Rebuffs Janssen's Imbruvica to Treat Waldenstrom's Macroglobulinemia
The UK’s price watchdog is not recommending Janssen’s Imbruvica for the treatment of Waldenstrom's macroglobulinemia, a rare type of non-Hodgkin's lymphoma.